Cornerstone Advisory
GILD icon

Cornerstone Advisory’s Gilead Sciences GILD Stock Holding History

Cornerstone Advisory’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$214K Buy
+1,433
New +$201K 0.02% 262
2022
Q1 		– Sell
-459
Closed -$34K – 418
2021
Q4 		$34K Buy
+459
New +$31.6K ﹤0.01% 466

Other funds holding GILD

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Cornerstone Advisory's GILD Position: Q3 2026 in Review

Cornerstone Advisory opened a new position in Gilead Sciences (GILD) in Q3 2026: 1,433 shares worth $214K. The stake represents 0.02% of the portfolio and ranks #262 among its holdings. This is a return to the name: Cornerstone Advisory previously reported a position in GILD as recently as Q4 2021.

Cornerstone Advisory first reported a position in GILD in Q4 2021 and has held it in 2 quarters since. 1,386 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Cornerstone Advisory held 1,433 shares of Gilead Sciences worth $214K as of Q3 2026.
  • Gilead Sciences was a new Cornerstone Advisory position in Q3 2026.
  • Gilead Sciences made up 0.02% of Cornerstone Advisory's portfolio in Q3 2026, its #262 holding.
  • Cornerstone Advisory first reported a position in Gilead Sciences in Q4 2021 and has held it in 2 quarters since.
  • 1,386 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Cornerstone Advisory's 13F filing for Q3 2026, filed 6 Nov 2026.